Last Updated : Wednesday, February 5, 2020 21:06:08

LUPIN gets USFDA nod to market tablets to treat leg joint pain

MUMBAI | BALTIMORE | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Lupin Ltd said of having got approval to market drug to treat Active Rheumatoid Arthritis (leg joint pain) and the product which has annual sales of US Dollar $44 million equivalent in US Markets according to the retail counter sales data available on December 2019, shall be manufactured at the company’s Pithampur (Unit 1) facility in India.

For LONG READ please CLICK / LOG ON / VISIT
https://datelinegujarat.blogspot.com


In case, if you wish to VERIFY the above news report, please CLICK here.


Follow DATELINE GUJARAT On :-

FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


SHARE THIS NEWS ON :-

Do NOT follow this link or you will be banned from the site!